Orgenesis Inc. EBIT

EBIT of ORGS for past 10 years: annual, quarterly and twelve month trailing (TTM) including EBIT growth rates and interactive chart. Earnings before interest and taxes is an indicator of a company's profitability. One can calculate it as revenue minus all expenses, excluding tax and interest. EBIT is also referred to as operating earnings, operating profit, and profit before interest and taxes. It is the amount of profit that a company earns before interest on debt and taxes are paid.

Highlights and Quick Summary

  • EBIT for the quarter ending September 29, 2021 was $-7.66 Million (a 229.29% increase compared to previous quarter)
  • Year-over-year quarterly EBIT decreased by -85.54%
  • Annual EBIT for 2020 was $-192 Million (a 771.76% increase from previous year)
  • Annual EBIT for 2019 was $-22 Million (a -34.79% decrease from previous year)
  • Annual EBIT for 2018 was $-33.7 Million (a 130.02% increase from previous year)
  • Twelve month EBIT ending September 29, 2021 was $-62.8 Million (a -2.62% decrease compared to previous quarter)
  • Twelve month trailing EBIT decreased by -34.4% year-over-year
Trailing EBIT for the last four month:
29 Sep '21 29 Jun '21 30 Mar '21 30 Dec '20
$-62.8 Million $-64.5 Million $-89 Million $-95.8 Million
Visit for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EBIT of Orgenesis Inc.

Most recent EBITof ORGS including historical data for past 10 years.

Interactive Chart of EBIT of Orgenesis Inc.

Orgenesis Inc. EBIT for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 $-7.66 $-2.33 $0.08
2020 $-52.93 $-9.35 $-26.77 $-6.73 $-191.57
2019 $-5.06 $-3.78 $-4.85 $-8.28 $-21.98
2018 $-10.24 $-0.65 $-2.76 $-3.24 $-33.7
2017 $-3.41 $-2.32 $-2.65 $-3.45 $-20.03
2016 $-1.67 $-2.44 $-2.65 $-3.97 $-3.49 $-11.4
2015 $-7.21
2014 $-4.58
2013 $-5.46
2012 $-2.67
2011 $-2.68

Business Profile of Orgenesis Inc.

Sector: Healthcare
Industry: Biotechnology
Orgenesis Inc., a biotech company, focusing on cell and gene therapies (CGTs). The company develops a Point of Care (POCare) platform includes three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company's POCare Network brings together patients, doctors, industry partners, research institutes, and hospitals for the clinical development and production of therapies worldwide. Orgenesis Inc. has a collaboration agreement with Savicell Diagnostics Ltd. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.